205 related articles for article (PubMed ID: 20156510)
1. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V
Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510
[TBL] [Abstract][Full Text] [Related]
2. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
[TBL] [Abstract][Full Text] [Related]
4. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
6. Characterization of HLA-G expression in renal cell carcinoma.
Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
8. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Lung Cancer; 2007 Nov; 58(2):267-74. PubMed ID: 17673327
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA-G in rheumatoid arthritis.
Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
[TBL] [Abstract][Full Text] [Related]
10. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection.
Weng PJ; Fu YM; Ding SX; Xu DP; Lin A; Yan WH
Hum Immunol; 2011 May; 72(5):406-11. PubMed ID: 21377504
[TBL] [Abstract][Full Text] [Related]
11. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
[TBL] [Abstract][Full Text] [Related]
12. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
13. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
[TBL] [Abstract][Full Text] [Related]
14. Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis.
Mach P; Blecharz P; Basta P; Marianowski P; Skret-Magierlo J; Kojs Z; Grabiec M; Wicherek L
Am J Reprod Immunol; 2010 May; 63(5):387-95. PubMed ID: 20146732
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
[TBL] [Abstract][Full Text] [Related]
16. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
Schütt P; Rebmann V; Brandhorst D; Wiefelspütz J; Ebeling P; Opalka B; Seeber S; Nowrousian MR; Moritz T; Grosse-Wilde H
Hum Immunol; 2008 Feb; 69(2):79-87. PubMed ID: 18361931
[TBL] [Abstract][Full Text] [Related]
18. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma.
Chen XY; Yan WH; Lin A; Xu HH; Zhang JG; Wang XX
Tissue Antigens; 2008 Oct; 72(4):335-41. PubMed ID: 18700878
[TBL] [Abstract][Full Text] [Related]
19. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
[TBL] [Abstract][Full Text] [Related]
20. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
